Document Detail


The application of transgenic mice for therapeutic antibody discovery.
MedLine Citation:
PMID:  22723098     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
In 2006, panitumumab, the first fully human antibody generated from transgenic mice, was approved for clinical use by the US Food and Drug Administration (FDA). Since then, a further seven such antibodies have been approved. In this chapter, we discuss how transgenic mice technologies can provide a powerful platform for creating human therapeutic antibodies.
Authors:
E-Chiang Lee; Michael Owen
Related Documents :
2455818 - Influenza a virus m2 protein: monoclonal antibody restriction of virus growth and detec...
20727998 - A novel series of anti-human glycophorin a (cd235a) antibodies defining five extra- and...
22526648 - Development of sensitive direct and indirect enzyme-linked immunosorbent assays (elisas...
9430738 - Designing an effective immunocontraceptive.
2415178 - Monoclonal antibodies against neoantigens of the terminal c5b-9 complex of human comple...
2668068 - Desmin-containing intermediate filaments: structural analysis using monoclonal antibodies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Methods in molecular biology (Clifton, N.J.)     Volume:  901     ISSN:  1940-6029     ISO Abbreviation:  Methods Mol. Biol.     Publication Date:  2012  
Date Detail:
Created Date:  2012-06-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9214969     Medline TA:  Methods Mol Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  137-48     Citation Subset:  IM    
Affiliation:
Kymab Ltd, Meditrina, Cambridge, UK, E-Chiang.Lee@kymab.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hybridoma technology for the generation of monoclonal antibodies.
Next Document:  Production of human or humanized antibodies in mice.